Novartis AG Long Term Debt 2010-2024 | NVS

Novartis AG long term debt for the quarter ending September 30, 2024 was $23.750B, a 31.45% increase year-over-year.

  • Novartis AG long term debt for 2023 was $18.436B, a 8.93% decline from 2022.
  • Novartis AG long term debt for 2022 was $20.244B, a 11.61% decline from 2021.
  • Novartis AG long term debt for 2021 was $22.902B, a 12.78% decline from 2020.

Novartis AG Long Term Debt 2010-2024 | NVS

  • Novartis AG long term debt for 2023 was $18.436B, a 8.93% decline from 2022.
  • Novartis AG long term debt for 2022 was $20.244B, a 11.61% decline from 2021.
  • Novartis AG long term debt for 2021 was $22.902B, a 12.78% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Merck (MRK)$255.9B
AstraZeneca (AZN)$200.6B
Pfizer (PFE)$155.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B